Please login to the form below

Not currently logged in

Karus names two division heads

Simon Roitt and Peter Finan strengthen research team

karus-Simon-RoittUK-based biopharma Karus Therapeutics has appointed new heads for two of its research divisions.

Dr Simon Roitt joins as head of clinical development and Dr Peter Finan joins as head of biology.

Dr Roitt (pictured right) is formerly director of clinical operations at Roche in the UK, a position he held for nine years. Prior to this he was director of clinical research at GE Healthcare in the UK.

His new colleague Dr Finan joins Karus from Novartis where he spent 16 years. Most recently he was VP, global head – respiratory disease.

In his new role Dr Finan will work on Karus' most advanced programme, a treatment for inflammatory disorders.

Dr Simon Kerry, chief executive of Karus said: “As we develop the business, the recruitment of highly experienced senior talent to our team will be a critical success factor. Simon and Peter both bring valuable clinical and scientific expertise to the Company, to help drive our programmes towards the clinic.”

29th October 2014

From: Research



Featured jobs

Subscribe to our email news alerts


Add my company

Established in 2002, Star is a full service outsourcing and resourcing company that works with the best people and opportunities...

Latest intelligence

The rise of real-world evidence
Demonstrating efficacy and value requires more than clinical trial data...
Digital health
The untapped potential to transform healthcare...
When is it time to rebrand?